{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:31:26Z","timestamp":1791311486362,"version":"4.3.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"French Ministry of Health","award":["PRHCI 2010"],"award-info":[{"award-number":["PRHCI 2010"]}]},{"name":"French Biomedicine Agency"},{"name":"Capucine association"},{"name":"Lorraine Region"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13045-017-0469-0","type":"journal-article","created":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T04:16:49Z","timestamp":1494217009000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I\/II multicenter clinical trial"],"prefix":"10.1186","volume":"10","author":[{"given":"Chongsheng","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Campidelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huili","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Venard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Jeulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Hugues","family":"Dalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Pochon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"D\u2019aveni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Paillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Vigouroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Jubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Ceballos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Marie-Cardine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Galambrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Cholle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Clerc Urmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Petitpain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"De Carvalho Bittencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Decot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Reppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00e8le","family":"Bensoussan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,8]]},"reference":[{"key":"469_CR1","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1182\/blood-2002-04-1203","volume":"101","author":"P Lang","year":"2003","unstructured":"Lang P, Handgretinger R, Niethammer D, Schlegel PG, Schumm M, Greil J, Bader P, Engel C, Scheel-Walter H, Eyrich M, Klingebiel T. Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia. Blood. 2003;101:1630\u20136.","journal-title":"Blood"},{"key":"469_CR2","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1749-6632.2001.tb03602.x","volume":"938","author":"R Handgretinger","year":"2001","unstructured":"Handgretinger R, Lang P, Schumm M, Pfeiffer M, Gottschling S, Demirdelen B, Bader P, Kuci S, Klingebiel T, Niethammer D. Immunological aspects of haploidentical stem cell transplantation in children. Ann N Y Acad Sci. 2001;938:340\u201357. discussion 357-348.","journal-title":"Ann N Y Acad Sci"},{"key":"469_CR3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/sj.bmt.1703873","volume":"31","author":"FR Loberiza Jr","year":"2003","unstructured":"Loberiza Jr FR, Serna DS, Horowitz MM, Rizzo JD. Transplant center characteristics and clinical outcomes after hematopoietic stem cell transplantation: what do we know? Bone Marrow Transplant. 2003;31:417\u201321.","journal-title":"Bone Marrow Transplant"},{"key":"469_CR4","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1038\/sj.leu.2403105","volume":"17","author":"M Mohty","year":"2003","unstructured":"Mohty M, Jacot W, Faucher C, Bay JO, Zandotti C, Collet L, Choufi B, Bilger K, Tournilhac O, Vey N, et al. Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen. Leukemia. 2003;17:2168\u201377.","journal-title":"Leukemia"},{"key":"469_CR5","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1365-2141.2004.05331.x","volume":"128","author":"T Feuchtinger","year":"2005","unstructured":"Feuchtinger T, Lucke J, Hamprecht K, Richard C, Handgretinger R, Schumm M, Greil J, Bock T, Niethammer D, Lang P. Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation. Br J Haematol. 2005;128:503\u20139.","journal-title":"Br J Haematol"},{"key":"469_CR6","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1182\/blood.V100.6.2235","volume":"100","author":"SR Lewin","year":"2002","unstructured":"Lewin SR, Heller G, Zhang L, Rodrigues E, Skulsky E, van den Brink MR, Small TN, Kernan NA, O'Reilly RJ, Ho DD, Young JW. Direct evidence for new T cell generation by patients after either T cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations. Blood. 2002;100:2235\u201342.","journal-title":"Blood"},{"key":"469_CR7","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.bbmt.2013.11.028","volume":"20","author":"YJ Chang","year":"2014","unstructured":"Chang YJ, Zhao XY, Huang XJ. Immune reconstitution after haploidentical hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014;20:440\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"key":"469_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/imr.12138","volume":"258","author":"AM Leen","year":"2014","unstructured":"Leen AM, Heslop HE, Brenner MK. Antiviral T cell therapy. Immunol Rev. 2014;258:12\u201329.","journal-title":"Immunol Rev"},{"key":"469_CR9","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/tid.12022","volume":"14","author":"S Matthes-Martin","year":"2012","unstructured":"Matthes-Martin S, Feuchtinger T, Shaw PJ, Engelhard D, Hirsch HH, Cordonnier C, Ljungman P. European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011). Transpl Infect Dis. 2012;14:555\u201363.","journal-title":"Transpl Infect Dis"},{"key":"469_CR10","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1182\/blood-2002-07-2152","volume":"102","author":"T Lion","year":"2003","unstructured":"Lion T, Baumgartinger R, Watzinger F, Matthes-Martin S, Suda M, Preuner S, Futterknecht B, Lawitschka A, Peters C, Potschger U, Gadner H. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood. 2003;102:1114\u201320.","journal-title":"Blood"},{"key":"469_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/sj.bmt.1705003","volume":"36","author":"MJ Tol van","year":"2005","unstructured":"van Tol MJ, Kroes AC, Schinkel J, Dinkelaar W, Claas EC, Jol-van der Zijde CM, Vossen JM. Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery. Bone Marrow Transplant. 2005;36:39\u201350.","journal-title":"Bone Marrow Transplant"},{"key":"469_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S1473-3099(03)00515-2","volume":"3","author":"T Walls","year":"2003","unstructured":"Walls T, Shankar AG, Shingadia D. Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. Lancet Infect Dis. 2003;3:79\u201386.","journal-title":"Lancet Infect Dis"},{"key":"469_CR13","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1086\/313514","volume":"29","author":"DS Howard","year":"1999","unstructured":"Howard DS, Phillips IG, Reece DE, Munn RK, Henslee-Downey J, Pittard M, Barker M, Pomeroy C. Adenovirus infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 1999;29:1494\u2013501.","journal-title":"Clin Infect Dis"},{"key":"469_CR14","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1128\/JCM.42.9.3963-3969.2004","volume":"42","author":"H Sarantis","year":"2004","unstructured":"Sarantis H, Johnson G, Brown M, Petric M, Tellier R. Comprehensive detection and serotyping of human adenoviruses by PCR and sequencing. J Clin Microbiol. 2004;42:3963\u20139.","journal-title":"J Clin Microbiol"},{"key":"469_CR15","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.trim.2011.03.002","volume":"24","author":"M D'Aveni","year":"2011","unstructured":"D'Aveni M, Aissi-Rothe L, Venard V, Salmon A, Falenga A, Decot V, Virion JM, Wang Y, Clement L, Latger-Cannard V, et al. The clinical value of concomitant Epstein Barr virus (EBV)-DNA load and specific immune reconstitution monitoring after allogeneic hematopoietic stem cell transplantation. Transpl Immunol. 2011;24:224\u201332.","journal-title":"Transpl Immunol"},{"key":"469_CR16","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1086\/319984","volume":"32","author":"P Bordigoni","year":"2001","unstructured":"Bordigoni P, Carret AS, Venard V, Witz F, Le Faou A. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2001;32:1290\u20137.","journal-title":"Clin Infect Dis"},{"key":"469_CR17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/sj.bmt.1703798","volume":"31","author":"P Ljungman","year":"2003","unstructured":"Ljungman P, Ribaud P, Eyrich M, Matthes-Martin S, Einsele H, Bleakley M, Machaczka M, Bierings M, Bosi A, Gratecos N, Cordonnier C. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2003;31:481\u20136.","journal-title":"Bone Marrow Transplant"},{"key":"469_CR18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jcv.2010.10.016","volume":"50","author":"K Paolino","year":"2011","unstructured":"Paolino K, Sande J, Perez E, Loechelt B, Jantausch B, Painter W, Anderson M, Tippin T, Lanier ER, Fry T, DeBiasi RL. Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001. J Clin Virol. 2011;50:167\u201370.","journal-title":"J Clin Virol"},{"key":"469_CR19","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.bbmt.2011.09.007","volume":"18","author":"DF Florescu","year":"2012","unstructured":"Florescu DF, Pergam SA, Neely MN, Qiu F, Johnston C, Way S, Sande J, Lewinsohn DA, Guzman-Cottrill JA, Graham ML, et al. Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients. Biol Blood Marrow Transplant. 2012;18:731\u20138.","journal-title":"Biol Blood Marrow Transplant"},{"key":"469_CR20","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.bbmt.2016.12.621","volume":"23","author":"MS Grimley","year":"2017","unstructured":"Grimley MS, Chemaly RF, Englund JA, Kurtzberg J, Chittick G, Brundage TM, Bae A, Morrison ME, Prasad VK. Brincidofovir for asymptomatic adenovirus viremia in pediatric and adult allogeneic hematopoietic cell transplant recipients: a randomized placebo-controlled phase II trial. Biol Blood Marrow Transplant. 2017;23:512\u201321.","journal-title":"Biol Blood Marrow Transplant"},{"key":"469_CR21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/sj.bmt.1702508","volume":"26","author":"S Chakrabarti","year":"2000","unstructured":"Chakrabarti S, Collingham KE, Fegan CD, Pillay D, Milligan DW. Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy? Bone Marrow Transplant. 2000;26:305\u20137.","journal-title":"Bone Marrow Transplant"},{"key":"469_CR22","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1182\/blood-2014-06-573725","volume":"125","author":"J Feucht","year":"2015","unstructured":"Feucht J, Opherk K, Lang P, Kayser S, Hartl L, Bethge W, Matthes-Martin S, Bader P, Albert MH, Maecker-Kolhoff B, et al. Adoptive T cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT. Blood. 2015;125:1986\u201394.","journal-title":"Blood"},{"key":"469_CR23","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1182\/blood-2009-08-239186","volume":"115","author":"HE Heslop","year":"2010","unstructured":"Heslop HE, Slobod KS, Pule MA, Hale GA, Rousseau A, Smith CA, Bollard CM, Liu H, Wu MF, Rochester RJ, et al. Long-term outcome of EBV-specific T cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood. 2010;115:925\u201335.","journal-title":"Blood"},{"key":"469_CR24","doi-asserted-by":"publisher","first-page":"5113","DOI":"10.1182\/blood-2013-02-486324","volume":"121","author":"AM Leen","year":"2013","unstructured":"Leen AM, Bollard CM, Mendizabal AM, Shpall EJ, Szabolcs P, Antin JH, Kapoor N, Pai SY, Rowley SD, Kebriaei P, et al. Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation. Blood. 2013;121:5113\u201323.","journal-title":"Blood"},{"key":"469_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1365-2141.2006.06108.x","volume":"134","author":"T Feuchtinger","year":"2006","unstructured":"Feuchtinger T, Matthes-Martin S, Richard C, Lion T, Fuhrer M, Hamprecht K, Handgretinger R, Peters C, Schuster FR, Beck R, et al. Safe adoptive transfer of virus-specific T cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol. 2006;134:64\u201376.","journal-title":"Br J Haematol"},{"key":"469_CR26","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/bjh.12251","volume":"161","author":"W Qasim","year":"2013","unstructured":"Qasim W, Gilmour K, Zhan H, Derniame S, McNicol AM, Ip W, Hiwarkar P, Veys P, Gaspar HB. Interferon-gamma capture T cell therapy for persistent adenoviraemia following allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2013;161:449\u201352.","journal-title":"Br J Haematol"},{"issue":"3","key":"469_CR27","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jaci.2016.03.032","volume":"138","author":"R Creidy","year":"2016","unstructured":"Creidy R, Moshous D, Touzot F, Elie C, Neven B, Gabrion A, Ville ML, Maury S, Ternaux B, Nisoy J, et al. Specific T cells for the treatment of cytomegalovirus and\/or adenovirus in the context of hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2016;138(3):920\u20134.e3.","journal-title":"J Allergy Clin Immunol"},{"key":"469_CR28","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1182\/blood-2009-08-236356","volume":"115","author":"A Moosmann","year":"2010","unstructured":"Moosmann A, Bigalke I, Tischer J, Schirrmann L, Kasten J, Tippmer S, Leeping M, Prevalsek D, Jaeger G, Ledderose G, et al. Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells. Blood. 2010;115:2960\u201370.","journal-title":"Blood"},{"key":"469_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1200\/JCO.2011.39.8495","volume":"31","author":"V Icheva","year":"2013","unstructured":"Icheva V, Kayser S, Wolff D, Tuve S, Kyzirakos C, Bethge W, Greil J, Albert MH, Schwinger W, Nathrath M, et al. Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific T cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation. J Clin Oncol. 2013;31:39\u201348.","journal-title":"J Clin Oncol"},{"key":"469_CR30","doi-asserted-by":"publisher","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","volume":"116","author":"T Feuchtinger","year":"2010","unstructured":"Feuchtinger T, Opherk K, Bethge WA, Topp MS, Schuster FR, Weissinger EM, Mohty M, Or R, Maschan M, Schumm M, et al. Adoptive transfer of pp 65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation. Blood. 2010;116:4360\u20137.","journal-title":"Blood"},{"key":"469_CR31","doi-asserted-by":"publisher","unstructured":"Pello OM, Innes AJ, Bradshaw A, Finn SA, Uddin S, Bray E, Olavarria E, Apperley JF, Pavlu J. BKV-specific T cells in the treatment of severe refractory haemorrhagic cystitis after HLA-haploidentical haematopoietic cell transplantation. Eur J Haematol. 2017. doi: 10.1111\/ejh.12848 . Epub ahead of print.","DOI":"10.1111\/ejh.12848"},{"key":"469_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/cid\/ciq042","volume":"52","author":"KS Peggs","year":"2011","unstructured":"Peggs KS, Thomson K, Samuel E, Dyer G, Armoogum J, Chakraverty R, Pang K, Mackinnon S, Lowdell MW. Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation. Clin Infect Dis. 2011;52:49\u201357.","journal-title":"Clin Infect Dis"},{"key":"469_CR33","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/pbc.24753","volume":"61","author":"M Nardo Di","year":"2014","unstructured":"Di Nardo M, Li Pira G, Amodeo A, Cecchetti C, Giorda E, Ceccarelli S, Brescia LP, Pirozzi N, Rutella S, Locatelli F, Bertaina A. Adoptive immunotherapy with antigen-specific T cells during extracorporeal membrane oxygenation (ECMO) for adenovirus-related respiratory failure in a child given haploidentical stem cell transplantation. Pediatr Blood Cancer. 2014;61:376\u20139.","journal-title":"Pediatr Blood Cancer"},{"key":"469_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bcmd.2007.07.003","volume":"40","author":"S Mackinnon","year":"2008","unstructured":"Mackinnon S, Thomson K, Verfuerth S, Peggs K, Lowdell M. Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells. Blood Cells Mol Dis. 2008;40:63\u20137.","journal-title":"Blood Cells Mol Dis"},{"key":"469_CR35","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/CJI.0b013e3181cc263b","volume":"33","author":"L Aissi-Rothe","year":"2010","unstructured":"Aissi-Rothe L, Decot V, Venard V, Jeulin H, Salmon A, Clement L, Kennel A, Mathieu C, Dalle JH, Rauser G, et al. Rapid generation of full clinical-grade human antiadenovirus cytotoxic T cells for adoptive immunotherapy. J Immunother. 2010;33:414\u201324.","journal-title":"J Immunother"},{"key":"469_CR36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jcyt.2013.07.008","volume":"16","author":"Y Wang","year":"2014","unstructured":"Wang Y, Aissi-Rothe L, Virion JM, De Carvalho BM, Ulas N, Audonnet S, Salmon A, Clement L, Venard V, Jeulin H, et al. Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy. Cytotherapy. 2014;16:122\u201334.","journal-title":"Cytotherapy"},{"key":"469_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/CJI.0000000000000105","volume":"39","author":"C Qian","year":"2016","unstructured":"Qian C, Wang Y, Cai H, Laroye C, De Carvalho BM, Clement L, Stoltz JF, Decot V, Reppel L, Bensoussan D. Adenovirus-specific T cell subsets in human peripheral blood and after IFN-gamma immunomagnetic selection. J Immunother. 2016;39:27\u201335.","journal-title":"J Immunother"},{"key":"469_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.patbio.2014.05.011","volume":"62","author":"T Guillaume","year":"2014","unstructured":"Guillaume T, Porcheron S, Audat F, Bancillon N, Berceanu A, Charbonnier A, Dulery R, Edy N, El Cheikh J, Hermet E, et al. Prophylactic, preemptive and curative use of donor lymphocyte infusion in patients undergoing allogeneic stem cell transplantation: guidelines of the SFGM-TC. Pathol Biol (Paris). 2014;62:193\u20136.","journal-title":"Pathol Biol (Paris)"},{"key":"469_CR39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/bmt.2014.227","volume":"50","author":"JJ Scarisbrick","year":"2015","unstructured":"Scarisbrick JJ, Dignan FL, Tulpule S, Gupta ED, Kolade S, Shaw B, Evison F, Shah G, Tholouli E, Mufti G, et al. A multicentre UK study of GVHD following DLI: rates of GVHD are high but mortality from GVHD is infrequent. Bone Marrow Transplant. 2015;50:62\u20137.","journal-title":"Bone Marrow Transplant"},{"key":"469_CR40","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1182\/blood-2014-01-514752","volume":"124","author":"G Socie","year":"2014","unstructured":"Socie G, Ritz J. Current issues in chronic graft-versus-host disease. Blood. 2014;124:374\u201384.","journal-title":"Blood"},{"key":"469_CR41","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S0140-6736(02)09672-1","volume":"360","author":"T Haque","year":"2002","unstructured":"Haque T, Wilkie GM, Taylor C, Amlot PL, Murad P, Iley A, Dombagoda D, Britton KM, Swerdlow AJ, Crawford DH. Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells. Lancet. 2002;360:436\u201342.","journal-title":"Lancet"},{"key":"469_CR42","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1182\/blood-2006-12-063008","volume":"110","author":"T Haque","year":"2007","unstructured":"Haque T, Wilkie GM, Jones MM, Higgins CD, Urquhart G, Wingate P, Burns D, McAulay K, Turner M, Bellamy C, et al. Allogeneic cytotoxic T cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood. 2007;110:1123\u201331.","journal-title":"Blood"},{"key":"469_CR43","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/bjh.13051","volume":"167","author":"MA Vickers","year":"2014","unstructured":"Vickers MA, Wilkie GM, Robinson N, Rivera N, Haque T, Crawford DH, Barry J, Fraser N, Turner DM, Robertson V, et al. Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease. Br J Haematol. 2014;167:402\u201310.","journal-title":"Br J Haematol"},{"key":"469_CR44","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/tan.12792","volume":"87","author":"A Ruggeri","year":"2016","unstructured":"Ruggeri A, Paviglianiti A, Gluckman E, Rocha V. Impact of HLA in cord blood transplantation outcomes. Hla. 2016;87:413\u201321.","journal-title":"Hla"},{"key":"469_CR45","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.jcyt.2015.03.614","volume":"17","author":"G Lucchini","year":"2015","unstructured":"Lucchini G, Perales MA, Veys P. Immune reconstitution after cord blood transplantation: peculiarities, clinical implications and management strategies. Cytotherapy. 2015;17:711\u201322.","journal-title":"Cytotherapy"},{"key":"469_CR46","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.jaci.2015.12.1311","volume":"137","author":"S Naik","year":"2016","unstructured":"Naik S, Nicholas SK, Martinez CA, Leen AM, Hanley PJ, Gottschalk SM, Rooney CM, Hanson IC, Krance RA, Shpall EJ, et al. Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes. J Allergy Clin Immunol. 2016;137:1498\u20131505.e1491.","journal-title":"J Allergy Clin Immunol"},{"key":"469_CR47","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10096-004-1165-x","volume":"23","author":"P Ljungman","year":"2004","unstructured":"Ljungman P. Treatment of adenovirus infections in the immunocompromised host. Eur J Clin Microbiol Infect Dis. 2004;23:583\u20138.","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Journal of Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-017-0469-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T22:58:14Z","timestamp":1602025094000},"score":1,"resource":{"primary":{"URL":"http:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-017-0469-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,8]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["469"],"URL":"https:\/\/doi.org\/10.1186\/s13045-017-0469-0","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,8]]},"article-number":"102"}}